Annual Debt To Equity
0.05
+0.05+100.00%
December 31, 2024
Summary
- As of March 6, 2025, FDMT annual debt to equity ratio is 0.05, with the most recent change of +0.05 (+100.00%) on December 31, 2024.
- During the last 3 years, FDMT annual debt to equity has risen by +0.05 (+100.00%).
- FDMT annual debt to equity is now at all-time high.
Performance
FDMT Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
0.05
+0.05+100.00%
December 31, 2024
Summary
- As of March 6, 2025, FDMT quarterly debt to equity ratio is 0.05, with the most recent change of +0.05 (+100.00%) on December 31, 2024.
- Over the past year, FDMT quarterly debt to equity has increased by +0.05 (+100.00%).
- FDMT quarterly debt to equity is now at all-time high.
Performance
FDMT Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
FDMT Debt To Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +100.0% | +100.0% |
3 y3 years | +100.0% | +100.0% |
5 y5 years | +100.0% | +100.0% |
FDMT Debt To Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -100.0% | at high | -100.0% |
5 y | 5-year | at high | -100.0% | at high | -100.0% |
alltime | all time | at high | -100.0% | at high | -100.0% |
4D Molecular Therapeutics Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | 0.05(>+9900.0%) | 0.05(>+9900.0%) |
Sep 2024 | - | 0.00(0.0%) |
Jun 2024 | - | 0.00(0.0%) |
Mar 2024 | - | 0.00(0.0%) |
Dec 2023 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2023 | - | 0.00(0.0%) |
Jun 2023 | - | 0.00(0.0%) |
Mar 2023 | - | 0.00(0.0%) |
Dec 2022 | 0.00 | 0.00(0.0%) |
Sep 2022 | - | 0.00(0.0%) |
Jun 2022 | - | 0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | 0.00(0.0%) |
Dec 2021 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2021 | - | 0.00(0.0%) |
Jun 2021 | - | 0.00(0.0%) |
Mar 2021 | - | 0.00(0.0%) |
Dec 2020 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2020 | - | 0.00(0.0%) |
Dec 2019 | 0.00(0.0%) | 0.00(0.0%) |
Jun 2019 | - | 0.00(0.0%) |
Dec 2018 | 0.00(0.0%) | 0.00 |
Dec 2017 | 0.00 | - |
FAQ
- What is 4D Molecular Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual debt to equity year-on-year change?
- What is 4D Molecular Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly debt to equity year-on-year change?
What is 4D Molecular Therapeutics annual debt to equity ratio?
The current annual debt to equity of FDMT is 0.05
What is the all time high annual debt to equity for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual debt to equity ratio is 0.05
What is 4D Molecular Therapeutics annual debt to equity year-on-year change?
Over the past year, FDMT annual debt to equity ratio has changed by +0.05 (+100.00%)
What is 4D Molecular Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of FDMT is 0.05
What is the all time high quarterly debt to equity for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly debt to equity ratio is 0.05
What is 4D Molecular Therapeutics quarterly debt to equity year-on-year change?
Over the past year, FDMT quarterly debt to equity ratio has changed by +0.05 (+100.00%)